Effect of nilvadipine on central visual field in retinitis pigmentosa: A 30-month clinical trial

Ophthalmologica

Volumn 225, Issue 2, 2011, Pages 120-126

  Nakazawa, Mitsuru ^a   Ohguro, Hiroshi ^a,b   Takeuchi, Kimio ^a   Miyagawa, Yasuhiro ^a   Ito, Tadashi ^a   Metoki, Tomomi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Calcium channel blocker; Nilvadipine; Ocular circulation; Photoreceptor; Retinitis pigmentosa; Visual field

Indexed keywords

ALPHA TOCOPHEROL NICOTINATE; NILVADIPINE; UNCLASSIFIED DRUG; XANTHOPHYLL; XANTHOPHYLL DIPALMITATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; OBSERVATIONAL STUDY; PERIMETRY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINITIS PIGMENTOSA; TREATMENT DURATION; VISUAL FIELD; VISUAL FIELD DEFECT;

ADMINISTRATION, ORAL; ADULT; AGED; CALCIUM CHANNEL BLOCKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUTEIN; MALE; MIDDLE AGED; NIFEDIPINE; PILOT PROJECTS; PROSPECTIVE STUDIES; RETINITIS PIGMENTOSA; TOCOPHEROLS; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS; YOUNG ADULT;

EID: 77957797154     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320500     Document Type: Article

References (45)

1. Berson El, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-Di Frano C, et al: A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:761-772. (Pubitemid 23170587)
2. Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM: Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 1989;107:1445-1452.
3. Grover S, Fishman GA, Fiscella RG, Adelman AE: Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 1997;17:222-231.
4. Portera-Cailliau C, Sung CH, Nathans J, Adler R: Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 1994;91:974-978.
5. Nicotera P, Orrenius S: The role of calcium in apoptosis. Cell Calcium 1998;23:173-180.
6. Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S: Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med 1999;5:1183-1187.
7. Pawlyk BS, Li T, Scimeca MS, Sandberg MA, Berson EL: Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse. Invest Ophthalmol Vis Sci 2002;43:1912-1915.
8. 2+ antagonist. Invest Ophthalmol Vis Sci 2002;43:919-926.
9. Donovan M, Cotter TG: Caspase-independent photoreceptor apoptosis in vivo and differential expression of apoptotic protease activating factor-1 and caspase-3 during retinal development. Cell Death Differ 2002;9:1220-1231.
10. Hart J, Wilkinson MF, Kelly MEM, Barnes S: Inhibitory action of diltiazem on voltagegated calcium channels in cone photoreceptors. Exp Eye Res 2003;76:597-604.
11. Sato M, Ohguro H, Ohguro I, Mamiya K, Takano Y, Yamazaki H, Metoki Y, Miyagawa Y, Ishikawa F, Nakazawa M: Study of pharmacological effects of nilvadipine on RCS rat retinal degeneration by microarray analysis. Biochem Biophys Res Commun 2003;306:826-831.
12. Takano Y, Ohguro H, Dezawa M, Ishikawa H, Yamazaki H, Ohguro I, Mamiya K, Metoki T, Ishikawa F, Nakazawa M: Study of drug effects of calcium channel blockers on degeneration of rd mouse. Biochem Biophys Res Commun 2004;313:1015-1022.
13. Vallazza-Deschamps G, Cia D, Gong J, Jellali A, Duboc A, Forster V, Sahel JA, Tessier L-H, Picaud S: Excessive activation of cyclic nucleotide-gated channels contributes to neuronal degeneration of photoreceptors. Eur J Neurosci 2005;22:1013-1022.
14. Sanges D, Comitato A, Tammaro R, Marigo V: Apoptosis in retinal degeneration involves cross-talk between apoptosis-inducing factor (AIF) and caspase-12 and is blocked by calpain inhibitors. Proc Natl Acad Sci USA 2006;103:17366-17371.
15. Pearce-Kelling SE, Aleman TS, Nickie A, Laties AM, Agurre GD, Jacobson SG, et al: Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa. Mol Vis 2001;7:42-47.
16. Bush RA, Kononen L, Machida S, Sieving PA: The effect of calcium channel blocker diltiazem on photoreceptor degeneration in the rhodopsin Pro213His rat. Invest Ophthalmol Vis Sci 2000;41:2697-2701.
17. Takeuchi K, Nakazawa M, Mizukoshi S: Systemic administration of nilvadipine delays photoreceptor degeneration of heterozygous retinal degeneration slow (rds) mouse. Exp Eye Res 2008;86:60-69.
18. Tokuma Y, Fujiwara T, Noguchi H: Absorption, distribution and excretion of nilvadipine, a new dihydropyrimidine calcium channel antagonist, in rats and dogs. Xenobiotica 1987;17:1341-1349.
19. D'Cruz PM, Yasumura D, Weir J, Matthes MT, Abderrahim H, La Vail MM, et al: Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet 2000;26:645-651.
20. Pittler SJ, Baehr W: Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Pro Natl Acad Sci USA 1991;88:8322-8326.
21. Travis GH, Brenman MB, Danielson PE, Kozak CA, Sutcliffe JG: Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature 1989;338:70-73.
22. Pasantes-Morales H, Quiroz H, Quesada O: Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study. Metab Brain Dis 2002;17:183-197.
23. Heckenlively JR: Autosomal dominant retinitis pigmentosa: autosomal recessive retinitis pigmentosa; in Heckenlively JR (ed): Retinitis Pigmentosa. Philadelphia, Lippincott, 1988, pp. 125-161.
24. Hirakawa H, Iijima H, Gohdo T, Imai M, Tsukahara S: Progression of defects in the central 10-degree visual field of patients with retinitis pigmentosa and choroideremia. Am J Ophthalmol 1999;127:436-442.
25. Berson EL: Long-term visual prognosis in patients with retinitis pigmentosa: the Ludwig von Sallmann lecture. Exp Eye Res 2007;85:7-14.
26. Terasaki H, Miyake Y, Nomura R, Piao CH, Hori K, Niwa T, et al: Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci 2001;42:229-234.
27. Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ: Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol 2008;146:172-182.
28. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, La Vail MM: Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990;347:83-86.
29. Cayourette M, Behn D, Sendtner M, Lachapelle P, Gravel C: Intraoculargene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci 1998;18:9282-9293.
30. Liang FQ, Dejneka NS, Cohen DR, Kransnoperova N V, Lem J, Maguire AM, et al: A AV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse. Mol Ther 2001;3:241-248.
31. Liang FQ, Aleman TS, Dejneka NS, Dudus L, Fisher KJ, Maguire AM, et al: Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther 2001;4:461-472.
32. Tao W, Wen R, Goddard MB, Sherman SD, O'Rourke PJ, Stabila PF, et al: Encapsulated cell-based delivery of CNTF reduced photo-receptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2002;43:3292-3298.
33. Bok D, Yasumura D, Mathes MT, Ruiz A, Duncan JL, Chappelow AV, et al: Effects of adeno-associated virus-vectored ciliary neu-rotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp Eye Res 2002;74:719-735.
34. Schlichtenbrede FC, MacNeil A, Bainbridge JW, Tschemutter M, Thrasher AJ, Smith AJ, et al: Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther 2003;10:523-527.
35. Wen R, Song Y, Kjiellstrom S, Tanikawa A, Liu Y, Li Y, et al: Regulation of rod phototransduction machinery by ciliary neurotrophic factor. J. Neurosci 2006;26:13523-13530.
36. Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR, et al: Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase 1 trial of CNT delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA 2006;103:3896-3901.
37. Koseki N, Araie M, Tomidokoro A, Nagahara M, Hasegawa T, Tamaki Y, et al: A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Ophthalmology 2008;115:2049-2057.
38. Cohn JN: Calcium, vascular smooth muscle, and calcium entry blockers in hypertension. Ann Intern Med 1983;988:806-809.
39. 2+ - antagonist on visual field in low-tension glaucoma. Graefe's Arch Clin Exp Ophthalmol 1989;227:408-412.
40. Netland PA, Chaturvedi N, Dreyer EB: Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 1993;115:608-613. (Pubitemid 23137645)
41. Tomita K, Araie M, Tamaki Y, Nagahara M, Sugiyama T: Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects. Invest Ophthalmol Vis Sci 1999;40:1144-1151.
42. Tomita G, Niwa Y, Shinohara H, Hayashi N, Yamamoto T, Kitazawa Y: Changes in optic nerve head blood flow and retrobulbar hemodynamics following calcium-channel blocker treatment of normal-tension glaucoma. Int Ophthalmol 1999;23:3-10.
43. Niwa Y, Yamamoto T, Harris A, Kagemann L, Kawakami H, Kitazawa Y: Relationship between the effect of carbon dioxide inhalation or nilvadipine on orbital blood flow in normal-tension glaucoma. J Glaucoma 2000;9:262-267.
44. Langham ME, Kramer T: Decreased choroidal blood flow associated with retinitis pigmentosa. Eye 1990;4:374-381.
45. Schmidt KG, Pillumat LE, Kohler K, Flammer J: Ocular pulse amplitude is reduced in patients with advanced retinitis pigmentosa. Br J Ophthalmol 2001;85:678-682.